Clinical Trials

NCT06885424 | ENROLLING_BY_INVITATION
400 participants

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-20
Start Date:
2025-07-31
Completion:
2030-03-31
Conditions
  • Solid Tumor Cancer
  • Solid Tumor, Unspecified, Adult
  • Colorectal Carcinoma
  • Colorectal Carcinoma (CRC)
  • Non Small Cell Lung Cancer
  • Small Cell Lung Cancer ( SCLC )
  • Pancreatic Cancer
  • NSCLC
  • Mesothelioma
  • Ovarian Cancer
  • Ovarian Carcinoma
  • Head and Neck (HNSCC)
  • Head and Neck Cancer
  • Renal Cell Carcinoma (Kidney Cancer)
  • Triple Negative Breast Cancer (TNBC)
Interventions
  • OTHER
No Results Yet
NCT06814496 | RECRUITING | PHASE1/PHASE2
30 participants

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2025-09-08
Completion:
2030-05-31
Conditions
  • Melanoma
  • Medullary Thyroid Cancer
  • Sinonasal Undifferentiated Carcinoma
  • Esthesioneuroblastoma
  • Bladder Cancer
  • Testicular Cancer
  • Glioblastoma Multiforme
  • Cervical Cancer
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Non Small Cell Lung Cancer
  • Merkel Cell Carcinoma
Interventions
  • DRUG
  • RADIATION
No Results Yet
NCT06803862 | ACTIVE_NOT_RECRUITING
21783 participants

RegiStry Of the multiFaceted medIcal cenTer

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-20
Start Date:
2021-01-01
Completion:
2026-12-31
Conditions
  • Chronic Non-communicable Diseases
  • Cardiovascular Diseases
  • COVID-19
  • Multimorbidity
No Results Yet
NCT06773403 | TERMINATED | PHASE4
5 participants

Upadacitinib for Prurigo Nodularis

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-20
Start Date:
2024-04-09
Completion:
2025-06-06
Conditions
  • Prurigo Nodularis
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page